TP53 and hematopoietic and lymphoid system neoplasm: CX-5461-mediated induction of the p53-dependent IRBC is a major mechanism of response in p53-wild-type tumor cells leading to cell cycle arrest and apoptosis, which seems to be the dominant response to CX-5461 in blood cancer models including lymphoma and AML models.